These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36296203)

  • 1. High Procalcitonin, C-Reactive Protein, and α-1 Acid Glycoprotein Levels in Whole Blood Samples Could Help Rapid Discrimination of Active Tuberculosis from Latent Tuberculosis Infection and Healthy Individuals.
    Kang YJ; Park H; Park SB; Lee J; Hyun H; Jung M; Lee EJ; Je MA; Kim J; Lee YS; Kim S
    Microorganisms; 2022 Sep; 10(10):. PubMed ID: 36296203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined analysis of whole blood interferon gamma release assay and complete blood count analysis for rapid discrimination of active tuberculosis and latent tuberculosis infection.
    Kang YJ; Park H; Park SB; Kim J; Lee J; Kim J; Park S; Lee YS; Kim S
    J Clin Tuberc Other Mycobact Dis; 2021 Aug; 24():100253. PubMed ID: 34278005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production.
    Jeong YH; Hur YG; Lee H; Kim S; Cho JE; Chang J; Shin SJ; Lee H; Kang YA; Cho SN; Ha SJ
    J Clin Microbiol; 2015 Feb; 53(2):504-10. PubMed ID: 25428147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Immunological Biomarkers for Detection of Mycobacterium tuberculosis Infection in a Setting Where M. tuberculosis Is Endemic, Ethiopia.
    Teklu T; Kwon K; Wondale B; HaileMariam M; Zewude A; Medhin G; Legesse M; Pieper R; Ameni G
    Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29311240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease.
    La Manna MP; Orlando V; Li Donni P; Sireci G; Di Carlo P; Cascio A; Dieli F; Caccamo N
    PLoS One; 2018; 13(3):e0192664. PubMed ID: 29543810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status.
    Tang J; Huang Y; Jiang S; Huang F; Ma T; Qi Y; Ma Y
    Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving T-cell assays for diagnosis of latent TB infection: Confirmation of the potential role of testing Interleukin-2 release in Iranian patients.
    Mamishi S; Pourakbari B; Shams H; Marjani M; Mahmoudi S
    Allergol Immunopathol (Madr); 2016; 44(4):314-21. PubMed ID: 26786720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
    Harada N
    Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis.
    Tebruegge M; Dutta B; Donath S; Ritz N; Forbes B; Camacho-Badilla K; Clifford V; Zufferey C; Robins-Browne R; Hanekom W; Graham SM; Connell T; Curtis N
    Am J Respir Crit Care Med; 2015 Aug; 192(4):485-99. PubMed ID: 26030187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of CD4 and CD8 response to QuantiFERON-TB Plus in patients with active tuberculosis and latent tuberculosis infection followed over time during treatment.
    Chiacchio T; Petruccioli E; Pepponi I; Vanini V; Gualano G; Cirillo D; Palmieri F; Ippolito G; Goletti D
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S141-S142. PubMed ID: 28043513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response.
    Butera O; Chiacchio T; Carrara S; Casetti R; Vanini V; Meraviglia S; Guggino G; Dieli F; Vecchi M; Lauria FN; Marruchella A; Laurenti P; Singh M; Caccamo N; Girardi E; Goletti D
    BMC Infect Dis; 2009 Nov; 9():182. PubMed ID: 19930588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of methylated HBHA expressed from Mycobacterium smegmatis in an IFN-γ release assay to aid discrimination between latent infection and active tuberculosis in BCG-vaccinated populations.
    Wen HL; Li CL; Li G; Lu YH; Li HC; Li T; Zhao HM; Wu K; Lowrie DB; Lv JX; Lu SH; Fan XY
    Eur J Clin Microbiol Infect Dis; 2017 Aug; 36(8):1415-1423. PubMed ID: 28429162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined IFN-γ and TNF-α release assay for differentiating active tuberculosis from latent tuberculosis infection.
    Kim JY; Park JH; Kim MC; Cha HH; Jeon NY; Park SY; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    J Infect; 2018 Oct; 77(4):314-320. PubMed ID: 29746954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The meta-analysis for ideal cytokines to distinguish the latent and active TB infection.
    Wei Z; Li Y; Wei C; Li Y; Xu H; Wu Y; Jia Y; Guo R; Jia J; Qi X; Li Z; Gao X
    BMC Pulm Med; 2020 Sep; 20(1):248. PubMed ID: 32948170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplex analysis of plasma cytokines/chemokines showing different immune responses in active TB patients, latent TB infection and healthy participants.
    Yao X; Liu Y; Liu Y; Liu W; Ye Z; Zheng C; Ge S
    Tuberculosis (Edinb); 2017 Dec; 107():88-94. PubMed ID: 29050777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of interferon-γ release assay for the diagnosis of latent tuberculosis infection in young children.
    Yun KW; Kim YK; Kim HR; Lee MK; Lim IS
    Korean J Pediatr; 2016 Jun; 59(6):256-61. PubMed ID: 27462354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordance between TST and QFT-TBGold Plus for Latent Tuberculosis Screening among Under-Five Children: An Interim Analysis.
    Surve S; Bhor V; Naukariya K; Begum S; Munne K; Tipre P; Sutar N; Jaiswal A; Bhonde G; Chauhan S; Shah I
    J Trop Pediatr; 2021 Dec; 67(6):. PubMed ID: 34904674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for
    Hong JY; Kim A; Park SY; Cho SN; Dockrell HM; Hur YG
    Front Cell Infect Microbiol; 2021; 11():599386. PubMed ID: 33869073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.